Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes

Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes

Cryptococcosis is a fungal disease caused by multiple Cryptococcus serotypes; particularly C. neoformans (serotypes A and D) and C. gattii (serotypes B and C). To date, there is no clinically available vaccine to prevent cryptococcosis. Mice given an experimental pulmonary vaccination with a C. neof...

Full description

Bibliographic Details
Main Authors:	Marley C. Caballero Van Dyke, Ashok K. Chaturvedi, Sarah E. Hardison, Chrissy M. Leopold Wager, Natalia Castro-Lopez, Camaron R. Hole, Karen L. Wozniak, Floyd L. Wormley
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-10-01
Series:	Frontiers in Immunology
Subjects:	Cryptococcus neoformans Cryptococcus gattii cryptococcosis host–fungal interaction fungal vaccines fungal immunology
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01359/full

Similar Items

Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome
by: Chrissy M Leopold Wager, et al.
Published: (2016-02-01)

CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis
by: Althea Campuzano, et al.
Published: (2020-02-01)

Systematic review on Cryptococcus neoformans/Cryptococcus gattii species complex infections with recommendations for practice in health and care settings
by: Mireille H. van der Torre, et al.
Published: (2022-07-01)

Interactions of Cryptococcus with Dendritic Cells
by: Karen L. Wozniak
Published: (2018-03-01)

Cryptococcus neoformans Cda1 and Cda2 coordinate deacetylation of chitin during infection to control fungal virulence
by: Rajendra Upadhya, et al.
Published: (2021-12-01)

Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages
by: Adithap Hansakon, et al.
Published: (2019-01-01)

Disseminated cryptococcosis with cutaneous involvement in an immunocompetent patient
by: Gabriely Lessa Sacht, et al.
Published: (2016-12-01)

<i>Cryptococcus bacillisporus</i> (VGIII) Meningoencephalitis Acquired in Santa Cruz, Bolivia
by: Luis Thompson, et al.
Published: (2021-01-01)

The status of cryptococcosis in Latin America
by: Carolina Firacative, et al.
Published: (2018-04-01)

First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Belém, Pará, Brazil
by: Solange do PSE Costa, et al.
Published: (2009-07-01)

Cryptococcosis in Atlántico, Colombia: an approximation of the prevalence of this mycosis and the distribution of the etiological agent in the environment
by: María Clara Noguera, et al.
Published: (2015-10-01)

Cryptococcal Virulence in Humans: Learning From Translational Studies With Clinical Isolates
by: Herdson Renney de Sousa, et al.
Published: (2021-04-01)

Cell wall composition in Cryptococcus neoformans is media dependent and alters host response, inducing protective immunity
by: Rajendra Upadhya, et al.
Published: (2023-05-01)

Cryptococcal meningitis epidemiology: 17 years of experience in a State of the Brazilian Pantanal
by: Joslaine de Oliveira Nunes, et al.

A Study of the Disruptive Effect of the Acetate Fraction of Punica granatum Extract on Cryptococcus Biofilms
by: Paulo C. M. Villis, et al.
Published: (2021-01-01)

What’s New in <i>Cryptococcus gattii</i>: From Bench to Bedside and Beyond
by: Justin Beardsley, et al.
Published: (2022-12-01)

Projecting Global Occurrence of Cryptococcus gattii
by: Deborah J. Springer, et al.
Published: (2010-01-01)

Eugenol Induces Phenotypic Alterations and Increases the Oxidative Burst in Cryptococcus
by: Júnia C. O. Alves, et al.
Published: (2017-12-01)

Cryptococcosis in Colombian children and literature review
by: Jairo Lizarazo, et al.
Published: (2014-09-01)

Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada
by: Laura MacDougall, et al.
Published: (2011-02-01)

Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan
by: Chang-Hua Chen, et al.
Published: (2015-08-01)

Cryptococcus gattii meningitis in a diabetic adult in South India
by: Mithilesh Kumar Jha, et al.
Published: (2019-01-01)

IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.
by: Chrissy M Leopold Wager, et al.
Published: (2018-10-01)

Development of a Real-Time PCR Assay to Identify and Distinguish between <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> Species Complexes
by: Enoch Tay, et al.
Published: (2022-04-01)

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis
by: Kyung J. Kwon-Chung, et al.
Published: (2017-02-01)

Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase
by: Silvia Katherine Carvajal, et al.
Published: (2023-08-01)

Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
by: Krystle L. Reagan, et al.
Published: (2019-09-01)

Advanced genetic techniques in fungal pathogen research
by: Robbi L. Ross, et al.
Published: (2024-04-01)

Cerebral Cryptococcomas: A Systematic Scoping Review of Available Evidence to Facilitate Diagnosis and Treatment
by: Daniel B. Chastain, et al.
Published: (2022-02-01)

Cryptococcal Antigen Testing in an Integrated Medical System: Eastern Wisconsin
by: Marianne Klumph, et al.
Published: (2020-01-01)

Membranous nephropathy with pulmonary cryptococcosis with improved 1-year follow-up results: A case report
by: Zhang Peipei, et al.
Published: (2021-02-01)

Primary cutaneous cryptococcosis caused by Cryptococcus gattii VGII in a tsunami survivor from Thailand
by: Manoon Leechawengwongs, et al.
Published: (2014-10-01)

Prevalence of cryptococcosis in Atlántico, department of Colombia assessed with an active epidemiological search
by: María Clara Noguera, et al.
Published: (2019-04-01)

Suscetibilidade a antifúngicos de variedades de Cryptococcus neoformans isoladas de pacientes em hospital universitário Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital
by: Paulo Roberto da Silva, et al.
Published: (2008-04-01)

Cryptococcus gattii Complex Infections in HIV-Infected Patients, Southeastern United States
by: Kaylee T. Bruner, et al.
Published: (2018-11-01)

Cryptococcus gattii molecular type VGII as agent of meningitis in a healthy child in Rio de Janeiro, Brazil: report of an autochthonous case Cryptococcus gattii tipo molecular VGII como agente causador de meningoencefalite em criança saudável no Rio de Janeiro, Brasil: relato de um caso autóctone
by: Vitor Laerte Pinto Junior, et al.
Published: (2010-12-01)

Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice.
by: Ashok K Chaturvedi, et al.
Published: (2014-01-01)

Pseudomonas aeruginosa Infection Modulates the Immune Response and Increases Mice Resistance to Cryptococcus gattii
by: Eluzia C. Peres-Emidio, et al.
Published: (2022-04-01)

An inherent T cell deficit in healthy males to C. neoformans infection may begin to explain the sex susceptibility in incidence of cryptococcosis
by: Tiffany E. Guess, et al.
Published: (2019-09-01)

Cryptococcus gattii meningoencephalitis in an HIV-negative patient from the Peruvian Andes Meningoencefalite causada por Cryptococcus gattii em um paciente HIV-negativo procedente dos Andes Peruanos
by: Ericson L. Gutierrez, et al.
Published: (2010-08-01)